Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01821352 · ClinicalTrials.gov registry record · NA
Study of Low Level Laser Therapy to Reduce Body Circumference in Obese Individuals
A NA study of Obesity, sponsored by Erchonia Corporation.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
- 2
- Study locations
NCT01821352: Completed NA study of Obesity, sponsored by Erchonia Corporation.
NCT01821352 is a NA study of Obesity that has completed, run by Erchonia Corporation. The registered enrollment target is 53 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01821352, a NA study of Obesity, has completed, sponsored by Erchonia Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine whether low level laser light therapy is effective in reducing circumference of the waist, hips and upper abdomen in obese individuals.
Primary Outcome
Individual measurements in inches of the waist, hips and upper abdomen were combined to calculate a total body circumference measurement. Change in combined circumference measurement from baseline to 4 weeks was calculated for each subject. Individual subject success was defined as a change of 3.0 inches or more in the combined circumference measurement across the evaluation period. A decrease in combined circumference measurement is positive for individual subject success. An increase in combin
Conditions Studied
Interventions
- DEVICE Placebo Laser
- DEVICE Erchonia Obesity Laser
Study Locations (2)
Indiana
- Surgeons Inc. - Noblesville
Michigan
- Bloomfield Laser and Cosmetic Surgery Center - Bloomfield Hills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-04 |
| Phase | NA |
What the finished NCT01821352 record still lists
NCT01821352 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Placebo Laser is the first listed.
NCT01821352 reports a single indexed study location in Indiana, Michigan.
Frequently Asked Questions
What is clinical trial NCT01821352 about?
NCT01821352 is a clinical study titled "Study of Low Level Laser Therapy to Reduce Body Circumference in Obese Individuals". The purpose of this study is to determine whether low level laser light therapy is effective in reducing circumference of the waist, hips and upper abdomen in obese individuals.
What is the current status of trial NCT01821352?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2013-03. Estimated completion is 2014-04.
What conditions does trial NCT01821352 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT01821352?
The interventions under investigation include: Placebo Laser (DEVICE), Erchonia Obesity Laser (DEVICE).
Who is sponsoring clinical trial NCT01821352?
This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01821352 being conducted?
This trial has 2 study locations across Indiana, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01821352's enrollment target sits among peer trials
53 700th of 1053 higher than 349 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia